The news behind the move, already on your screen.
Every alert comes with the headline. No second app. No 30 seconds of searching while the stock runs.
7 days free, then $29.99/month. Cancel anytime.
XYZ Therapeutics announces FDA clearance for its lead device
- RVOL
- 12.6x
- Float
- 4.2M
- Float rotation
- 3.1x
- Volume
- 13.0M
The why arrives with the alert.
- Scanner hits
- Open a news site
- Search the ticker
- Read
- Guess
The stock keeps moving the whole time.
- Alert + headline, together
- Decide
Sniper puts real-time news on the Stock Card, so you spend the first minutes of the move deciding, not reading.
Real catalyst or PR pump?
Not every gap up is the same. Catalyst Analysis helps you tell which one you are looking at before you are in.
Low-float stock moving on an FDA approval
Stock running on a press release
They trade differently. And because Sniper focuses on small-cap catalysts, the news you see relates to the stocks you actually trade, not large-cap earnings noise.
Stop searching. Start deciding.
The headline arrives with every Sparker alert, next to the numbers that matter.
Start 7-day free trial7 days free, then $29.99/month. Cancel anytime.
News in context, not a feed you have to scroll.
- 01The headline
- 02Price move
- 03RVOL
- 04Float
- 05Float rotation
- 06Daily volume
Who it is for
Traders who have been caught in a press-release pump, or who lose the first minutes of a move reading instead of deciding.
Before you start the trial.
Is the news real-time?
Yes. Real-time news is delivered on the Stock Card with the alert.
Does Sniper tell me whether a catalyst is good?
Catalyst Analysis helps separate real catalysts from press-release pumps to inform your read. It is informational, not a recommendation.
Do you cover large caps?
The focus is small-cap catalysts.
Is each headline labeled by catalyst type?
Yes. Every headline is classified by the kind of catalyst behind it and shown on the Stock Card as a catalyst line. It describes the news and is not a recommendation.
